Cowen & Co initiates coverage on Pharmasset (Nasdaq: VRUS) with an Outperform rating.

Cowen analyst says, "We are initiating ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE